Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.96% | 56.16% | 48.62% | 51.49% | 50.12% |
| Total Depreciation and Amortization | -- | -- | -76.27% | -100.00% | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 137.29% | -- |
| Change in Net Operating Assets | -20.91% | -64.52% | 3,300.00% | -50.80% | 11.92% |
| Cash from Operations | -109.20% | -82.42% | -120.69% | -18.97% | 167.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 100.00% | 100.00% | 442.22% | -34.76% | -200.00% |
| Total Debt Repaid | 37.68% | -- | -- | 59.77% | -133.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 51.56% | -172.22% | -175.00% | 200.00% | -139.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.27% | -143.84% | -150.82% | 80.00% | -37.14% |